Form 4: Nuvalent Director Emily Conley Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director Emily Conley exercised stock options and sold shares of Nuvalent, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 15, 2024, Emily Conley, a director of Nuvalent, Inc., executed a series of transactions involving the company's Class A Common Stock.
• Conley exercised a stock option to acquire 13,333 shares at a price of $9.36 per share.
• Simultaneously, Conley sold a total of 13,333 shares in multiple transactions at weighted average prices ranging from $79.81 to $84.44.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2023.
• Following these transactions, Conley directly owns 8 shares of Class A Common Stock.
• Conley also directly owns 6,667 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine transactions under a pre-existing trading plan. There is no indication of positive or negative implications for the company.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives and directors to have pre-arranged trading plans to sell shares over time.

Key Dates